CHARLES MINARD to Recombinant Fusion Proteins
This is a "connection" page, showing publications CHARLES MINARD has written about Recombinant Fusion Proteins.
Connection Strength
0.103
-
Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report. Clin Cancer Res. 2017 Oct 15; 23(20):6062-6069.
Score: 0.103